PATENT CLAIM ANALYSIS

Application Number: 15870813
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-05
Patent Classification: ["424", "439000"]

Abstract:
A method of determining a stage of CKD may comprise: measuring a creatinine level; determining a creatinine level; determining a glomerular filtration rate; and determining a stage of CKD.

Claim (Index 1):
A method of determining a stage of chronic kidney disease (CKD) and inhibiting CKD, the method comprising:\n measuring a current creatinine level of an individual from a biochemistry test; determining a glomerular filtration rate (GFR) based on the current creatinine level; determining a stage of CKD based on the GFR; and based on the stage of CKD, administering a dosage of a supplement to the individual, the supplement consisting of lysine, zinc, and vitamin C, wherein the supplement comprises a range of less than about 200 mg of zinc.

Metadata:
- Claim Count in Document: 22.0
- Percentile: 86.0
- Lexical Diversity: 1.78947
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15870822', '15817574', '15666244', '13359381', '12352473']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6208633820390527
- 35 USC 102 Novelty (BERT): 0.5021237397321383
- Combined Prediction Score: 0.6089894178083612
- Mean Citation Score: 161.577984
- Max Citation Score: 242.91177
- Similarity Product: 165.7400258051884

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test